Sains Malaysiana 53(2)(2024): 239-248
http://doi.org/10.17576/jsm-2024-5302-01
Evaluation of
Encapsulated Astaxanthin from White Shrimp Shells (Litopenaeus
vannamei) on Hepatotoxicity
(Penilaian Astaxantin Berkapsul daripada Kulit Udang Putih (Litopenaeus
vannamei) terhadap Kehepatoksikan)
NIRACHA YANYIUM1#,
WANIDA SUKKETSIRI1#, PENNAPA CHONPATHOMPIKUNLERT2,
WANWIMOL KLAYPRADIT3, JIRAWAT SAETAN1, SEBASTIEN MARAIS4 & SUPITA TANASAWET1,*
1Division of Health and Applied
Sciences, Faculty of Science, Prince of Songkla University,
Hat Yai, Songkhla, 90112, Thailand
2Biodiversity
Research Centre (BRC), Thailand Institute of Scientific and Technological
Research (TISTR), Pathumthani, 12120, Thailand
3Department
of Fishery Products, Faculty of Fisheries, Kasetsart University, Bangkok,
10900, Thailand
4Univ. Bordeaux, CNRS, INSERM, Bordeaux Imaging Center, BIC,
UAR 3420, US 4, F-33000 Bordeaux, France
Diserahkan: 13 Jun 2023/Diterima: 1
Februari 2024
Abstract
Recent advances in astaxanthin encapsulation have been
reported, but hepatotoxic effect remains unclear. The
present investigation therefore aimed to examine the effects of encapsulated astaxanthin from white shrimp shells (Litopenaeus vannamei) on liver toxicity. Wistar rats were divided into 6
groups as control (C), and receiving vitamin E (VE), astaxanthin commercial
(AC), astaxanthin extracted from white shrimp shells (AE), astaxanthin
encapsulation into powder form (AP), and blank powder (BP). The evaluation of
liver in response to astaxanthin administration was then assessed in terms of
biochemical parameters and histopathological features. Liver enzymes, aspartate
aminotransferase (AST) and alanine aminotransferase (ALT), showed no
significant differences among all groups of treatment. Histopathological study
showed no abnormal changes on liver tissue including hepatic inflammation. Our
data demonstrated that astaxanthin encapsulation did not increase the
expression of NF-ҡB nuclear translocation and CYP2E1 in comparison with the control group. Additionally, in
this study, the consumption of astaxanthin and vitamin E resulted in a
reduction in the oxidative stress index (OSI), while the levels of antioxidant
enzymes, including glutathione peroxidase (GPx) and superoxide dismutase (SOD),
were significantly increased compared to the control group. Our data suggested
that astaxanthin encapsulation does not cause hepatic toxicity, contributing
useful information in the applications of astaxanthin encapsulation technology.
Keywords:
Astaxanthin; encapsulation; histopathology; liver; white shrimp shells
Abstrak
Perkembangan
terkini dalam enkapsulasi astaxantin telah dilaporkan, namun kesan hepatotoksik
masih tidak jelas. Oleh itu, penyelidikan ini bertujuan untuk mengkaji kesan
astaxantin terkapsul daripada kulit udang putih (Litopenaeus vannamei) terhadap ketoksikan hati. Tikus Wistar
dibahagikan kepada 6 kumpulan sebagai kawalan (C), serta menerima vitamin E
(VE), astaxantin komersial (AC), astaxantin yang diekstrak daripada kulit udang
putih (AE), astaxantin enkapsulasi dalam bentuk serbuk (AP) dan serbuk kosong
(BP). Penilaian hati sebagai tindak balas kepada perlakuan astaxantin
kemudiannya dinilai daripada segi parameter biokimia dan ciri histopatologi. Enzim
hati, aspartat aminotransferase (AST) dan alanin aminotransferase (ALT), tidak
menunjukkan perbezaan yang signifikan antara semua kumpulan rawatan. Kajian
histopatologi mendedahkan tiada perubahan abnormal pada tisu hati termasuk
keradangan hepatik. Data kami menunjukkan bahawa enkapsulasi astaxantin tidak
meningkatkan pengekspresn translokasi nuklear NF-ҡB dan CYP2E1 berbanding
kumpulan kawalan. Di samping itu, dalam kajian ini, penggunaan astaxantin dan
vitamin E mengakibatkan pengurangan dalam indeks tekanan oksidatif (OSI),
manakala tahap enzim antioksidan, termasuk glutation peroksidase (GPx) dan
superoksida dismutase (SOD), meningkat dengan signifikan berbanding kumpulan
kawalan. Data kami mencadangkan bahawa enkapsulasi astaxantin tidak menyebabkan
ketoksikan hepatik, lantas menyumbang maklumat berguna dalam aplikasi teknologi
pengkapsulan astaxantin.
Kata
kunci: Astaxantin; enkapsulasi; hati; histopatologi; kulit udang putih
RUJUKAN
Al-kasmi, B., Alsirawan, B.,
Bashimam, M. & El-zein, H. 2017. Mechanical microencapsulation: The best
technique in taste masking for the manufacturing scale- effect of polymer
encapsulation on drug targeting. Journal of Controlled Release 260:
134-141.
Ambati, R.R., Phang, S.M.,
Ravi, S. & Aswathanarayana, R.G. 2014. Astaxanthin: Sources, extraction,
stability, biological activities and its commercial application - A review. Marine
Drugs 12: 128-152.
Arauz, J., Ramos-Tovar, E.
& Muriel, P. 2016. Redox state and methods to evaluate oxidative stress in
liver damage: From bench to bedside. Annals of Hepatology 15(2):
160-173.
Chen, Z., Tian, R., She, Z.,
Cai, J. & Li, H. 2020. Role of oxidative stress in the pathogenesis of
nonalcoholic fatty liver disease. Free Radical Biology and Medicine 152:
116-141.
Chintong, S., Phatvej, W.,
Rerk-Am, U., Waiprib, Y. & Klaypradit, W. 2019. In vitro antioxidant, antityrosinase, and cytotoxic activities of
astaxanthin from shrimp waste. Antioxidants 8: 128.
Cichoz-Lach, H. &
Michalak, A. 2014. Oxidative stress as a crucial factor in liver disease. World
Journal of Gastroenterology 20(25): 8082-8091.
Coelho, J.F., Ferreira, P.C.,
Alves, P., Cordeiro, R., Fonseca, A.C., Gois, J.R. & Gil, M.H. 2010. Drug
delivery systems: Advanced technologies potentially applicable in personalized
treatments. The EPMA Journal 1(1): 164-209.
Gasmi, B. & Kleiner, D.E.
2020. Liver histology: Diagnostic and prognostic features. Clinics in Liver
Disease 24(1): 61-74.
Giannini, E.G., Testa, R.
& Savarino, V. 2005. Liver enzyme alteration: A guide for clinicians. Canadian
Medical Association Journal 172(3): 367-379.
Greuter, T. & Shah, V.H.
2016. Hepatic sinusoids in liver injury, inflammation, and fibrosis: New
pathophysiological insights. Journal of Gastroenterology 51: 511-519.
Inglut, C.T., Sorrin, A.J.,
Kuruppu, T., Vig, S., Cicalo, J., Ahmad, H. & Huang, H.C. 2020.
Immunological and toxicological considerations for the design of liposomes. Nanomaterials 10(2): 190.
Kuedo, Z., Sangsuriyawong, A.,
Klaypradit, W., Tipmanee, V. & Chonpathompikunlert, P. 2016. Effects of
astaxanthin from Litopenaeus vannamei on carrageenan-induced edema and
pain behavior in mice. Molecules 21: 382.
Kleiner, D.E. 2017.
Histopathological challenges in suspected drug-induced liver injury. Liver
International 38(2): 198-209.
Kobayashi, A., Suzuki, Y.
& Sugai, S. 2020. Specificity of transaminase activities in the prediction
of drug-induced hepatotoxicity. The Journal of Toxicological Sciences 45(9): 515-537.
Luedde, T. & Schwabe, R.F.
2011. NF-kB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 8(2): 108-118.
Martinez-Alvarez, O., Calvo,
M.M. & Gomez-Estaca, J. 2020. Recent advances in astaxanthin micro/nanoencapsulation
to improve its stability and functionality as a food ingredient. Marine
Drugs 18(8): 406.
Meunier, L. & Larrey, D.
2019. Drug-induced liver injury: Biomarkers, requirements, candidates, and
validation. Frontier in Pharmacology 10: 1482.
Qin, J.D., Cao, Z.H., Li,
X.F., Kang, X.L., Xue, Y., Li, Y.L., Zhang, D., Liu, X.Y. & Xue, Y.Z. 2014.
Effect of ammonium pyrrolidine dithhiocarbamate (PDTC) on NF-kB activation and
CYP2E1 content of rats with immunological liver injury. Pharmaceutical Biology 52(11): 1460-1466.
Qin, L., Kang, X., Li, X.,
Wang, T., Liu, F., Jia, J., Jin, Z. & Xue, Y. 2019. NF-kB-mediated
regulation of rat CYP2E1 by two independent signaling pathways. PLoS ONE 14(12): e0225531.
Sangsuriyawong, A.,
Limpawattana, M., Siriwan, D. & Klaypradit, W. 2019. Properties and
bioavailability assessment of shrimp astaxanthin loaded liposomes. Food
Science and Biotechnology 28(2): 529-537.
Sukketsiri, W.,
Chonpathompikunlert, P., Tanasawet, S., Choosri, N. & Wongtawatchai, T.
2016. Effects of Apium graveolens extract
on the oxidative stress in the liver of adjuvant-induced arthritic rats. Preventive
Nutrition and Food Science 21(2): 79-84.
Sun, T., Kang, Y., Liu, J.,
Zhang, Y., Ou, L., Liu, X., Lai, R. & Shao, L. 2021. Nanomaterials and
hepatic diseases: Toxicokinetics, disease types, intrinsic mechanisms, liver
susceptibility, and influencing factors. Journal of Nanobiotechnology 19(1):
108.
Takasima, T.,
Chonpathompikunlert, P., Sroyraya, M., Hutamekalin, P., Limpawattana, M. &
Klaypradit, W. 2019. Effects of astaxanthin from shrimp sell on oxidative
stress and behavior in animal model of Alzheimer’s disease. Marine Drugs 17(11): 628.
Takasima, T., Limpawattana, M.
& Klaypradit, W. 2015. Astaxanthin encapsulated in beads using ultrasonic
atomizer and application in yogurt as evaluated by consumer sensory profile. LWT-Food
Science and Technology 62: 431-437.
Tanasawet, S., Sukketsiri, W.,
Chonpathompikunlert, P., Klaypradit, W., Sroyraya, M. & Hutamekalin, P.
2020. Apoptotic effect of astaxanthin from white shrimp shells on lung cancer
A549 cells. Tropical Journal of Pharmaceutical Research 19(9):
1835-1842.
Xiong, F. & Chang, M.X.
2020. Astaxanthin and its effects in inflammatory responses and
inflammation-associated diseases: Recent advances and future directions. Molecules 25(22): 5342.
Xu, L., Yu, Y., Sang, R., Li,
J., Ge, B. & Zhang, X. 2018. Protective effects of taraxasterol against
ethanol-induced liver injury by regulating CYP2E1.Nrf2/HO-1 and NF-kB signaling
pathways in mice. Oxidative Medicine and Cellular Longevity 2018:
8284107.
Yao, Y., Zang, Y., Qu, J.,
Tang, M. & Zhang, T. 2019. The toxicity of metallic nanoparticles on liver:
The subcellular damages, mechanisms, and outcomes. International Journal of
Nanomedicine 14: 8787-8804.
*Pengarang untuk
surat-menyurat; email: supita.t@psu.ac.th
|